Subscribe / Renew |
|
Contact Us |
|
► Subscribe to our Free Weekly Newsletter |
home | Welcome, sign in or click here to subscribe. | login |
FEATURED NOTICE | |
Port of Bremerton Airport Feasibility Study | |
New Bid Calls | 9 |
New Consultant Notices | 3 |
New Supply Bids | 0 |
RESERVOIR 3 REPLACEMENT, PHASE 1 Walsh Construction Company II, LLC |
CITY HALL ADDITION & MODERNIZATION - CITY OF BUCKLEY Kassel & Associates |
POST IAF AIRLINE REALIGNMENT, MC/ CM BID PACKAGE #1 (CONTROLS, INSULATION) Shinn Mechanical Inc. |
2024 OLYMPIC REGION REGION WIDE CHIP SEAL Granite Construction Company |
SR 169 & SR 509 FISH PASSAGE - WSDOT Kiewit Infrastructure West Co. |
more » |
print email to a friend reprints add to mydjc |
May 20, 2020
Seattle-based Kubota Vision said it has reached positive clinical results from myopia control tests in humans. The company uses a tabletop optical device to project myopically de-focused images on the peripheral retina of subjects to prevent progression of myopia. Based on these clinical results, Kubota plans to develop wearable devices to prevent myopia in children. It expects to have prototype smart glasses available by December and smart contact lenses at a later date. Kubota Vision is a subsidiary of Kubota Pharmaceutical Holdings Co. of Tokyo.
MyDJC | Business | Construction | Real Estate | Architecture & Engineering | Environment | Machinery | Technology | Weekend
Copyright 2024 Seattle Daily Journal of Commerce | Terms of Service | Privacy Policy | Contact Us | Advertising | Site Index